Qingfeng Yu

发表

Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle

G. Zeng, Wenqi Wu, M. Hennenberg, 2021, Acta pharmaceutica Sinica. B.

HnRNPL as a key factor in spermatogenesis: Lesson from functional proteomic studies of azoospermia patients with sertoli cell only syndrome.

Wenbin Guo, X. Mao, Qingfeng Yu, 2012, Journal of proteomics.

Evaluating the Lower Urinary Tract Syndrome with a Telemedicine Application: An Exploration of the Electronic Audiovisual Prostate Symptom Score

Qingfeng Yu, Di Gu, Ziyu Liu, 2022, Frontiers in Surgery.

Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3

C. Stief, C. Gratzke, A. Herlemann, 2018, British journal of pharmacology.

Percutaneous nephrolithotomy versus flexible ureteroscopic lithotripsy in the treatment of upper urinary tract stones: a meta-analysis comparing clinical efficacy and safety

G. Zeng, Wenqi Wu, Yaoan Wen, 2020, BMC Urology.

Phosphofructokinase-M inhibits cell growth via modulating the FOXO3 pathway in renal cell carcinoma cells.

G. Zeng, Wenqi Wu, Qingfeng Yu, 2020, Biochemical and biophysical research communications.

Nitric Oxide Synthase in Male Urological and Andrologic Functions

Qingfeng Yu, Liren Zhong, Jingping Li, 2017 .

Inhibition of agonist‐induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region

C. Stief, M. Schott, C. Gratzke, 2017, European journal of pharmacology.

Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cells.

C. Stief, M. Hennenberg, Yiming Wang, 2020, Life sciences.

Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766

C. Stief, C. Gratzke, A. Spek, 2020, Frontiers in Pharmacology.

M378 exhibits anti-inflammatory activities through NLRP3 signaling pathway.

Weijie Li, Guanglin Xu, Yujian Li, 2022, European journal of pharmacology.

Non‐Adrenergic, Tamsulosin‐Insensitive Smooth Muscle Contraction is Sufficient to Replace α1‐Adrenergic Tension in the Human Prostate

C. Stief, C. Gratzke, A. Herlemann, 2017, The Prostate.

Inhibition of smooth muscle contraction and ARF6 activity by the inhibitor for cytohesin GEFs, secinH3, in the human prostate.

C. Stief, M. Schott, C. Gratzke, 2018, American journal of physiology. Renal physiology.

Inhibition of smooth muscle contraction and ARF 6 activity 1 by the inhibitor for cytohesin GEFs , secinH 3 in the human 2 prostate 3 4

C. Stief, M. Schott, C. Gratzke, 2022 .

Phosphoproteomics identifies potential downstream targets of the integrin α2β1 inhibitor BTT-3033 in prostate stromal cells

C. Stief, M. Hennenberg, Bingsheng Li, 2021, Annals of translational medicine.

Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases

C. Stief, C. Gratzke, A. Herlemann, 2018, Front. Physiol..

Inhibition of Adrenergic and Non‐Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10‐Selective Inhibitor TC‐E 5005

C. Stief, M. Schott, C. Gratzke, 2016, The Prostate.

Ghrelin Aggravates Prostate Enlargement in Rats with Testosterone-Induced Benign Prostatic Hyperplasia, Stromal Cell Proliferation, and Smooth Muscle Contraction in Human Prostate Tissues

C. Stief, Chunxiao Liu, C. Gratzke, 2019, Oxidative medicine and cellular longevity.

New strategies for inhibition of non‐adrenergic prostate smooth muscle contraction by pharmacologic intervention

C. Stief, C. Gratzke, A. Herlemann, 2019, The Prostate.

Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein‐coupled receptor kinase 2/3, CMPD101

Frank Strittmatter, Christian Gratzke, Christian G. Stief, 2018, European journal of pharmacology.

MP45-11 NEW STRATEGIES FOR INHIBITION OF NON-ADRENERGIC PROSTATE SMOOTH MUSCLE CONTRACTION BY PHARMACOLOGIC INTERVENTION

C. Stief, C. Gratzke, A. Herlemann, 2018 .

A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate

C. Stief, C. Gratzke, A. Herlemann, 2019, The Journal of Biological Chemistry.

Ligand–Receptor Interactions and Structure–Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors

A. Tamalunas, M. Hennenberg, Qingfeng Yu, 2024, International journal of molecular sciences.